Maridia, also known as sibutramine, is a
prescription drug taken to prevent or lessen
obesity. It is in the class of anorectics and
decreases appetite but also has some antidepressant
effects. The FDA approved Maridia in 1997 for the
treatment of obesity.
The drug increases adrenaline and serotonin levels
in the brain and this is thought to decrease appetite.
Known side effects include headache, dry mouth,
insomnia and high blood pressure. Patients
suffering from hypertension, angina or other
cardiovascular problems should avoid Maridia.
In 2005 Maridia was included in a hearing in the
United States Senate to study cardiovascular problems
resulting in death that appeared to be related to
certain drugs. Maridia was not with drawn from
the market but petitions where filed with the FDA to
NOTICE: This webpage is
Copyrighted content. No portion of this page may be copied
to any other webpage, forum, blog or other domain page or
offline publication without written permission from
FactsOfLaw.com. Violators will be prosecuted to the fullest extent of the law.
The information provided by FactsOfLaw.com does not
constitute legal advice or any other type of advice and is
provided for educational purposes only without warranty of any
kind. FactsOfLaw.com has not reviewed the information on this
page for accuracy and is not responsible for any errors,
omissions or inaccuracies. For legal advice you should
consult a licensed attorney.